HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SUNSHINE PHARMA

43.540

-0.200-0.46%

Volume:99.23K

Turnover:4.33M

Market Cap:25.08B

PE:20.92

High:43.900

Open:43.800

Low:43.120

Close:43.740

52wk High:62.300

52wk Low:40.540

Shares:576.00M

HK Float Shares:112.00M

Volume Ratio:0.27

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(LYR):2.081

ROE:5.87%

ROA:3.32%

PB:2.60

PE(LYR):20.92

PS:5.95

Loading ...

Overview Company News Filings

Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi

MT Newswires Live

BRIEF-Sunshine Lake Pharma Enters Strategic Agreement With Shenzhen Xtalpi Technology

SUNSHINE PHARMA (06887) Enters Strategic Pact with Shenzhen Jingtai to Establish AI-Driven Drug Discovery Platform

Sunshine Lake Pharma - Under Deal, Parties to Establish Jv to Build AI-Driven Drug Research and Development Platform, Others

THOMSON REUTERS

Hong Kong Stock Movement | SUNSHINE PHARMA (06887) Rises Over 6% in Afternoon Session; Class 1 New Drug Ologliflozin Approved for Market Launch; AI R&D Platform Recently Unveiled

BRIEF-Sunshine Lake Pharma Says Olorigliflozin Capsules Gets Marketing Aproval From China NMPA

Sunshine Lake Pharma Gets China Nod for Marketing of Glycemic Control Drug

MT Newswires Live

Sunshine Lake Pharma - Olorigliflozin Capsules Gets Marketing Aproval From China Nmpa

THOMSON REUTERS

Sunshine Lake Pharma Launches AI Platform for PROTAC Research

MT Newswires Live

Hong Kong Stock Announcement Highlights | BIODLINK-B Receives 99% Premium Cash Offer from WUXI XDC, Resumes Trading on January 15

Guangdong HEC Pharmaceutical Unveils AI-Driven Drug for MASH Showing Promising Preclinical Results

Sunshine Lake Pharma Enrolls First Patient in Hepatitis B Virus-Targeting Drug

MT Newswires Live

Sunshine Pharma (06887) Repurchases 88,800 Shares for HK$3.8983 Million on January 5

SUNSHINE PHARMA (06887): HECN30227 Completes Enrollment of First Patient in China

Guangdong HEC Pharmaceutical Launches Phase I Trial of Novel Hepatitis B siRNA Drug

Sunshine Pharma (06887) Repurchases 49,100 Shares for HK$2.192 Million on January 2

Zhixiang Hong Kong Stock Repurchase Statistics | January 1

62-Year-Old Wealthy Woman Transfers Core Assets to Son, Mother-Son Fortune Totals 40 Billion Yuan

Sunshine Pharma (06887): Equity Transfer Among Controlling Shareholder Group Members

Huafu Securities Initiates Coverage on SUNSHINE PHARMA (06887) with "Buy" Rating, Citing Strong Innovation Pipeline and Growth Potential

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/06887/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06887\",,,,,undefined,":{"symbol":"06887","market":"HK","secType":"STK","nameCN":"SUNSHINE PHARMA","latestPrice":43.54,"timestamp":1771574918006,"preClose":43.74,"halted":0,"volume":99228,"delay":0,"changeRate":-0.004572473708276242,"floatShares":112000000,"shares":576000000,"eps":2.080908,"marketStatus":"Market Closed","change":-0.2,"latestTime":"02-20 16:08:38","open":43.8,"high":43.9,"low":43.12,"amount":4329134,"amplitude":0.017833,"askPrice":43.54,"askSize":500,"bidPrice":43.38,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":-0.754,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":7,"adr":0,"listingDate":1754496000000,"exchange":"SEHK","adjPreClose":43.74,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":0.2723246811610864,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06887\",,,,,undefined,":{"symbol":"06887","floatShares":112000000,"roa":"3.32%","roe":"5.87%","lyrEps":2.080908,"volumeRatio":0.2723246811610864,"shares":576000000,"dividePrice":0,"high":43.9,"amplitude":0.017833,"preClose":43.74,"low":43.12,"week52Low":40.54,"pbRate":"2.60","psRate":"5.95","week52High":62.3,"institutionHeld":0,"latestPrice":43.54,"committee":0.52381,"eps":2.080908,"divideRate":0,"volume":99228,"delay":0,"ttmEps":-0.754,"open":43.8,"prevYearClose":45.6,"prevWeekClose":43.38,"prevMonthClose":42.58,"prevQuarterClose":45.6,"fiveDayClose":43.72,"twentyDayClose":42.4,"sixtyDayClose":44.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06887\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06887\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06887","date":"2026-02-20","current":-57.745358,"percent":0.128788,"low":26.481481,"twenty":46.148611,"median":49.625248,"eighty":52.6697,"high":87.951651,"avg":49.683677,"sd":5.02045,"marketCap":25080444034},"quantilePoints":[{"date":"2025-08-08","current":87.951651,"twenty":38.775515,"median":57.216566,"eighty":75.657617,"marketCap":46410789719},{"date":"2025-08-15","current":53.544743,"twenty":50.854913,"median":50.910211,"eighty":53.207453,"marketCap":28212434399},{"date":"2025-08-22","current":46.053295,"twenty":48.528483,"median":50.885695,"eighty":53.358103,"marketCap":24189138855},{"date":"2025-08-29","current":48.593903,"twenty":46.280797,"median":49.970466,"eighty":52.516937,"marketCap":25645423745},{"date":"2025-09-05","current":50.421125,"twenty":47.199187,"median":49.797857,"eighty":51.668677,"marketCap":26583369945},{"date":"2025-09-12","current":49.629542,"twenty":47.419761,"median":49.970466,"eighty":51.668677,"marketCap":26213128024},{"date":"2025-09-19","current":54.62816,"twenty":48.205808,"median":50.411246,"eighty":53.54124,"marketCap":28832802350},{"date":"2025-09-26","current":53.850125,"twenty":48.404456,"median":50.853346,"eighty":54.601279,"marketCap":28348411270},{"date":"2025-10-03","current":53.088089,"twenty":48.593903,"median":50.910211,"eighty":54.493754,"marketCap":28013950763},{"date":"2025-10-10","current":52.114945,"twenty":48.663506,"median":51.880943,"eighty":54.471659,"marketCap":27460360958},{"date":"2025-10-17","current":51.235542,"twenty":48.675057,"median":51.667489,"eighty":54.265854,"marketCap":26975969878},{"date":"2025-10-24","current":51.392091,"twenty":48.841643,"median":51.235542,"eighty":53.929637,"marketCap":27068234846},{"date":"2025-10-31","current":50.069287,"twenty":49.32788,"median":50.982905,"eighty":53.853315,"marketCap":26410846952},{"date":"2025-11-07","current":53.644815,"twenty":49.627824,"median":51.208128,"eighty":53.746971,"marketCap":28279212544},{"date":"2025-11-14","current":53.755029,"twenty":49.70171,"median":51.476684,"eighty":54.315924,"marketCap":28417609996},{"date":"2025-11-21","current":46.009908,"twenty":49.627824,"median":51.313817,"eighty":54.001174,"marketCap":24311818941},{"date":"2025-11-28","current":50.562563,"twenty":49.32788,"median":51.158242,"eighty":53.853315,"marketCap":26814506185},{"date":"2025-12-05","current":49.62909,"twenty":48.806915,"median":50.946558,"eighty":53.793067,"marketCap":26364714468},{"date":"2025-12-12","current":45.875244,"twenty":48.689091,"median":50.853346,"eighty":53.708932,"marketCap":24415617029},{"date":"2025-12-19","current":48.167088,"twenty":48.455966,"median":50.812822,"eighty":53.658169,"marketCap":25695793454},{"date":"2025-12-24","current":47.090792,"twenty":48.188424,"median":50.667849,"eighty":53.624801,"marketCap":25199869253},{"date":"2026-01-02","current":47.915151,"twenty":47.916975,"median":50.562563,"eighty":53.544743,"marketCap":25741925938},{"date":"2026-01-09","current":46.425642,"twenty":47.58113,"median":50.411246,"eighty":53.527229,"marketCap":25003806197},{"date":"2026-01-16","current":46.054632,"twenty":47.232705,"median":50.329975,"eighty":53.374504,"marketCap":24884593070},{"date":"2026-01-23","current":50.623376,"twenty":47.090792,"median":50.178609,"eighty":53.359475,"marketCap":27326969797},{"date":"2026-01-30","current":45.230483,"twenty":47.047797,"median":49.970466,"eighty":53.088089,"marketCap":24527453077},{"date":"2026-02-06","current":44.437932,"twenty":46.420917,"median":49.799183,"eighty":52.900313,"marketCap":24158792439},{"date":"2026-02-13","current":45.701196,"twenty":46.174063,"median":49.62909,"eighty":52.681598,"marketCap":24988278874},{"date":"2026-02-20","current":45.935922,"twenty":46.148611,"median":49.625248,"eighty":52.6697,"marketCap":25080444034}],"updateTime":1771731595950},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06887\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606749552","title":"Sunshine Lake Pharma Signs AI Drug R&D Framework with Shenzhen XtalPi","url":"https://stock-news.laohu8.com/highlight/detail?id=2606749552","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606749552?lang=en_us&edition=fundamental","pubTime":"2026-01-27 12:06","pubTimestamp":1769486766,"startTime":"0","endTime":"0","summary":"Sunshine Lake Pharma  said it has entered into a cooperation framework agreement with Shenzhen XtalPi Technology to pursue a joint venture focused on AI-driven drug research and development, according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were up over 3% in Tuesday morning trade.The parties plan to build an AI drug R&D platform, including a joint laboratory for innovative drug discovery, joint development of AI large models across the drug development lifecycle, and the creation of a \"Model-as-a-Service\" business model, the filing showed.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06887","BK4543","BK4588","BK1191","AI","BK4585","BK4023","BK4551","BK4528","BK4587"],"gpt_icon":0},{"id":"2606419432","title":"BRIEF-Sunshine Lake Pharma Enters Strategic Agreement With Shenzhen Xtalpi Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2606419432","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606419432?lang=en_us&edition=fundamental","pubTime":"2026-01-26 23:21","pubTimestamp":1769440888,"startTime":"0","endTime":"0","summary":"BRIEF-Sunshine Lake Pharma Enters Strategic Agreement With Shenzhen Xtalpi TechnologyJan 26  - Sunshine Lake Pharma Co Ltd 6887.HK:ENTERS STRATEGIC AGREEMENT WITH SHENZHEN XTALPI TECHNOLOGYUNDER DEAL, PARTIES TO ESTABLISH JV TO BUILD AI-DRIVEN DRUG RESEARCH AND DEVELOPMENT PLATFORM, OTHERSFurther company coverage: 6887.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YP01V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1161898004","title":"SUNSHINE PHARMA (06887) Enters Strategic Pact with Shenzhen Jingtai to Establish AI-Driven Drug Discovery Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1161898004","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161898004?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:14","pubTimestamp":1769426098,"startTime":"0","endTime":"0","summary":"SUNSHINE PHARMA (06887) announced that on January 26, 2026, the Company entered into a strategic cooperation agreement with Shenzhen Jingtai Technology Co., Ltd. Pursuant to this agreement, the two...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2606883214","title":"Sunshine Lake Pharma - Under Deal, Parties to Establish Jv to Build AI-Driven Drug Research and Development Platform, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2606883214","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606883214?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:09","pubTimestamp":1769425754,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YP01V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"1123543895","title":"Hong Kong Stock Movement | SUNSHINE PHARMA (06887) Rises Over 6% in Afternoon Session; Class 1 New Drug Ologliflozin Approved for Market Launch; AI R&D Platform Recently Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1123543895","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123543895?lang=en_us&edition=fundamental","pubTime":"2026-01-22 14:08","pubTimestamp":1769062102,"startTime":"0","endTime":"0","summary":"SUNSHINE PHARMA (06887) surged more than 6% during the afternoon session. As of the time of writing, the stock was up 6.55%, trading at HK$46.2, with a turnover of HK$30.6289 million. On January 16,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159819","BK1610","BK1191","02800","06887"],"gpt_icon":1},{"id":"2603997614","title":"BRIEF-Sunshine Lake Pharma Says Olorigliflozin Capsules Gets Marketing Aproval From China NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603997614","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603997614?lang=en_us&edition=fundamental","pubTime":"2026-01-16 23:40","pubTimestamp":1768578050,"startTime":"0","endTime":"0","summary":"BRIEF-Sunshine Lake Pharma Says Olorigliflozin Capsules Gets Marketing Aproval From China NMPAJan 16 (Reuters) - Sunshine Lake Pharma Co Ltd 6887.HK:OLORIGLIFLOZIN CAPSULES GETS MARKETING APROVAL FROM CHINA NMPAFurther company coverage: 6887.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YG1OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2603273993","title":"Sunshine Lake Pharma Gets China Nod for Marketing of Glycemic Control Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2603273993","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603273993?lang=en_us&edition=fundamental","pubTime":"2026-01-16 20:27","pubTimestamp":1768566426,"startTime":"0","endTime":"0","summary":"Sunshine Lake Pharma  obtained marketing approval for the Olorigliflozin Capsules from China's National Medical Products Administration, according to a Friday Hong Kong bourse filing.The approval is for use of the drug as monotherapy or in combination with metformin to improve glycemic control in adults with type 2 diabetes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2603960711","title":"Sunshine Lake Pharma - Olorigliflozin Capsules Gets Marketing Aproval From China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2603960711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603960711?lang=en_us&edition=fundamental","pubTime":"2026-01-16 19:36","pubTimestamp":1768563390,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YG1OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2603627769","title":"Sunshine Lake Pharma Launches AI Platform for PROTAC Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2603627769","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603627769?lang=en_us&edition=fundamental","pubTime":"2026-01-15 11:50","pubTimestamp":1768449020,"startTime":"0","endTime":"0","summary":"Sunshine Lake Pharma  has launched an artificial intelligence-powered research and development platform focused on PROTAC  drug discovery, according to a Wednesday Hong Kong bourse filing.Shares of the firm were down nearly 1% in Thursday morning trade.The company said the platform integrates data analysis, computational modelling, and laboratory validation to support the design of PROTAC compounds.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1137624204","title":"Hong Kong Stock Announcement Highlights | BIODLINK-B Receives 99% Premium Cash Offer from WUXI XDC, Resumes Trading on January 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1137624204","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137624204?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:14","pubTimestamp":1768403671,"startTime":"0","endTime":"0","summary":"Major Developments: Longqi Technology (09611) will conduct its IPO from January 14 to January 19, planning a global offering of 52.2591 million H shares. Hutchmed (00013) announced that the results...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","LU1522347837.USD","BK1191","HK0000500386.USD","BK1141","HK0000252152.HKD","BK1560","BK1516","LU1720050803.USD","00998","LU1497733557.USD","LU1634259391.SGD","LU0264606111.USD","09887","06887","LU1794554557.SGD","BK1574","LU0456827905.SGD","LU0210526637.USD","BK1521","BK1161","06030","BK1147","LU0572940350.SGD","02268","BK1231","LU1497733631.SGD","01875","LU1497734951.SGD","BK1564","LU1634259557.SGD","LU0572939691.SGD","LU0051755006.USD","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603616476","title":"Guangdong HEC Pharmaceutical Unveils AI-Driven Drug for MASH Showing Promising Preclinical Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616476","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603616476?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:10","pubTimestamp":1768396231,"startTime":"0","endTime":"0","summary":"Guangdong HEC Pharmaceutical Co. Ltd. has announced that its first AI-driven small molecule drug, HEC169584, developed for the treatment of metabolic-associated steatohepatitis , has entered Phase I clinical trials. Preclinical research indicates that HEC169584 demonstrates high in vitro activity against THR-β cells and strong liver targeting, potentially reducing impacts on the thyroid axis, heart, and other tissues. The company has not specified whether these research results have already been presented or if they will be presented at a future date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong HEC Pharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Servic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL91CPc6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2601224881","title":"Sunshine Lake Pharma Enrolls First Patient in Hepatitis B Virus-Targeting Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2601224881","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601224881?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:18","pubTimestamp":1767619107,"startTime":"0","endTime":"0","summary":"Sunshine Lake Pharma (HKG:6887) completed the enrollment of the first domestic subject in HECN30227, according to a Monday filing with the Hong Kong bourse.HECN30227 eliminates hepatitis B surface antigen (HBsAg) originating from both cccDNA and intDNA.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1129514855","title":"Sunshine Pharma (06887) Repurchases 88,800 Shares for HK$3.8983 Million on January 5","url":"https://stock-news.laohu8.com/highlight/detail?id=1129514855","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129514855?lang=en_us&edition=fundamental","pubTime":"2026-01-05 20:42","pubTimestamp":1767616970,"startTime":"0","endTime":"0","summary":"Sunshine Pharma (06887) announced that on January 5, 2026, the company repurchased 88,800 shares at a cost of HK$3.8983 million. The repurchase price ranged from HK$43.22 to HK$44.90 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1133580396","title":"SUNSHINE PHARMA (06887): HECN30227 Completes Enrollment of First Patient in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1133580396","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133580396?lang=en_us&edition=fundamental","pubTime":"2026-01-05 19:21","pubTimestamp":1767612117,"startTime":"0","endTime":"0","summary":"HECN30227, a Class 1 new drug independently developed and globally owned by the Group, is capable of simultaneously eliminating hepatitis B surface antigen (HBsAg) derived from both cccDNA and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2601883887","title":"Guangdong HEC Pharmaceutical Launches Phase I Trial of Novel Hepatitis B siRNA Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2601883887","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601883887?lang=en_us&edition=fundamental","pubTime":"2026-01-05 19:09","pubTimestamp":1767611364,"startTime":"0","endTime":"0","summary":"Guangdong HEC Pharmaceutical Co. Ltd. has announced the initiation of a Phase I clinical trial for HECN30227, an siRNA therapeutic targeting hepatitis B virus. HECN30227 is a Class 1 new drug independently developed by the company, with global intellectual property rights. Preclinical data indicate that HECN30227 demonstrates pan-genotypic activity and is effective in reducing hepatitis B surface antigen  levels, including efficacy against strains resistant to nucleoside analogues. The company has not yet presented clinical results, as the announcement pertains to the commencement of the Phase I trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong HEC Pharmaceutical Co. Ltd. published the original content used to generate th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL78mYZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887","BK1191"],"gpt_icon":0},{"id":"1188578492","title":"Sunshine Pharma (06887) Repurchases 49,100 Shares for HK$2.192 Million on January 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1188578492","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188578492?lang=en_us&edition=fundamental","pubTime":"2026-01-02 18:46","pubTimestamp":1767350770,"startTime":"0","endTime":"0","summary":"Sunshine Pharma (06887) announced that on January 2, 2026, it executed a share repurchase, buying back 49,100 shares at a total cost of HK$2.192 million.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1174407833","title":"Zhixiang Hong Kong Stock Repurchase Statistics | January 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1174407833","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174407833?lang=en_us&edition=fundamental","pubTime":"2026-01-01 09:13","pubTimestamp":1767230019,"startTime":"0","endTime":"0","summary":"A total of 58 companies conducted share buybacks on December 31, 2025. Among them, TENCENT (00700) executed the largest buyback by value, repurchasing 1.061 million shares for HK$635 million. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823413660.USD","LU0828237510.HKD","LU1718418525.SGD","LU0456842615.SGD","02886","BK1183","LU0449509016.USD","SG9999014914.USD","LU0823397103.USD","01024","LU0417516571.SGD","LU0516423174.USD","LU1810669033.SGD","LU2008162690.USD","06608","IE00B5MMRT66.SGD","LU0348783233.USD","LU0188438112.USD","LU1769817179.HKD","LU2498475776.HKD","SGXZ99366536.SGD","LU1328615791.USD","BK1160","LU0633140560.USD","BK1517","LU2152927971.USD","06609","LU0821914370.USD","LU0080751232.USD","LU0683595622.HKD","LU0254981946.USD","BK1515","HK0000306701.USD","LU0414403682.SGD","LU1814569148.SGD","01995","LU0784639295.USD","SG9999018857.SGD","BK1566","LU1868837722.USD","LU0051755006.USD","LU0251144936.SGD","LU0047713382.USD","IE00BZ08YS42.EUR","81024","SG9999007991.SGD","LU0348788117.USD","SG9999002562.SGD","LU0456827905.SGD","LU0326950275.SGD","IE00B543WZ88.USD","LU0589944569.HKD","LU0054450605.USD","LU1251922891.USD","LU0607220059.USD","LU0214875030.USD","LU1282649067.USD","LU0348816934.USD","SG9999006514.SGD","LU0070217475.USD","LU1328277881.USD","IE00BF5LJ272.USD","LU0648948544.HKD","SG9999001903.USD","LU0370786039.SGD","02038","LU0516422440.USD","LU0084288322.USD","LU0210526637.USD","LU2039709279.SGD","LU1226288097.SGD","LU2462611646.USD","BK1132","LU1868837565.USD","LU2097828805.USD","LU0067412154.USD","LU0269904917.USD","02598","06098","LU0871576103.HKD","LU1770034418.SGD","LU0737861772.HKD","BK1516","LU1481107354.HKD","02121","LU0634319403.HKD","LU0384037296.USD","LU1048588211.SGD","LU1808992512.USD","LU0117841782.USD","LU1196710351.USD","SG9999000327.SGD","LU2097828714.EUR","LU2087589342.USD","HK0000252152.HKD","SG9999002828.SGD","IE00B8HQ1Z84.USD","LU1785774172.SGD","LU0345775950.USD","LU0106252389.USD","LU0320764755.SGD","SG9999001846.SGD","BK1615","HK0000306685.HKD","LU0149534421.HKD","LU0531970944.HKD","LU1196710864.SGD","LU1655091459.SGD","LU2045819591.USD","IE00BGV7N243.SGD","SG9999004220.SGD","BK1117","BK1521","BK1209","LU1224709979.USD","BK1104","LU0611395673.USD","LU0320764599.SGD","LU1048596156.SGD","LU1105468828.SGD","LU0499858438.USD","LU0608807433.USD","LU0791591158.USD","LU0898667661.SGD","02416","LU0449515922.USD","IE00B0JY6N72.USD","LU1226287792.SGD","LU0880133367.SGD","BK1249","LU0642271901.SGD","IE00B067MR52.USD","BK1504","LU0588546209.SGD","LU0651946864.USD","BK1193","LU0106959298.USD","LU0127658192.USD","LU0264606111.USD","BK1128","LU0441854154.USD","LU0823039010.USD","LU0455707207.USD","LU2293587155.HKD","LU0823413587.USD","LU1235295612.USD","LU0211977185.USD","LU0509642566.USD","LU0588545490.SGD","LU0320764243.SGD","LU0633140727.USD","LU0259732245.USD","LU0143863784.USD","LU2488822045.USD","LU0149721374.USD","LU0140636845.USD","LU0828238088.HKD","LU0541501648.USD","01588","SGXZ90724238.SGD","00345","BK1124","LU1504937902.USD","LU0823040885.USD","02299","06887","LU1719994722.HKD","LU2237443978.SGD","SG9999017495.SGD","LU0210527791.USD","LU1880383366.USD","LU0072462343.USD","LU1303224171.USD","BK1590","SG9999002463.SGD","00700","LU0052750758.USD","LU0329678170.USD","BK1604","02517","09886","LU0868486357.SGD","LU2237443895.HKD","IE00B3M56506.USD","LU2257852520.SGD","LU0326948709.USD","LU0501845795.SGD","LU0823426480.USD","01600","LU2317271919.USD","LU0463099449.HKD","LU2177674079.SGD","LU0516422366.SGD","01810","LU1282649141.HKD","BK1619","SGXZ31699556.SGD","IE0003795394.USD","SG9999001051.SGD","01516","LU0072913022.USD","BK1587","LU1226288253.USD","BK1618","00314","LU1734074674.USD","02652","01897","LU0345769631.USD","SG9999014898.SGD","LU0235996351.USD","BK1116","LU0878004406.USD","LU2362540622.SGD","LU1951186391.HKD","06868","BK1167","LU0128522157.USD","LU0244354667.USD","LU0823397285.USD","BK1229","IE00B031J352.USD","LU1366334651.USD","LU2237443622.USD","LU0348735423.USD","09896","LU0307460666.USD","LU0348766576.USD","03798","LU0328353924.USD","LU0972618739.USD","09922","LU0650527681.SGD","LU1226288170.HKD","LU0164880469.USD","LU0878005551.USD","LU1831875114.USD","LU0261947096.USD","LU0039217434.USD","BK1258","LU0561508036.HKD","LU1725190679.HKD","02219","LU0192582467.USD","LU0287142896.SGD","LU1642822792.SGD","LU0918141887.USD","LU1675838814.USD","BK1607","IE00BZ08YR35.GBP","06078","LU0469268626.HKD","LU0651947912.USD","LU0672654166.SGD","LU0531971595.HKD","LU0823041008.USD","BK1609","LU1974910355.USD","LU0029874905.USD","LU2476274308.USD","LU0516423091.SGD","LU0228659784.USD","BK1608","LU0128522744.USD","LU0196878994.USD","LU0169518387.USD","LU0396098781.USD","LU0708995583.HKD","LU2097828557.USD","SGXZ51526630.SGD","LU2247934214.USD","LU0327786744.USD","BK1535","BK1144","LU0345769128.USD","LU2051468812.USD","SG9999013353.USD","SG9999001093.SGD","BK1161","BK1506","LU1515016050.SGD","LU0315178854.USD","09966","02509","LU0164872284.USD","BK1585","LU0819121731.USD","BK1500","LU0819123356.HKD","LU0231483743.USD","LU1813983027.USD","LU2226246903.HKD","LU0918141705.HKD","01651","LU0329678337.USD","BK1518","IE0034224299.USD","LU0164865239.USD","LU0348825331.USD","LU1051769294.HKD","LU2237443549.SGD","LU0106259558.USD","HK0000320223.HKD","LU2449936058.SGD","BK1591","LU0588545904.SGD","LU1044874839.SGD","LU0228367735.SGD","LU0516422952.EUR","LU0502904849.HKD","LU0577902454.USD","LU1051768304.USD","LU0588545730.USD","02586","BK1191","BK1549","LU0605514214.HKD","SG9999001069.SGD","SG9999003461.SGD","LU1807302812.USD","IE0032834883.USD","LU0261950983.USD","LU0791590937.USD","LU0211331839.USD","BK1246","IE00BQXX3F31.USD","LU0543330483.HKD","IE0032431581.USD","BK1142","IE0009570106.USD","HTCD.SI","LU2279701549.SGD","LU1226287529.USD","IE00B8L5B284.USD","LU0797268264.HKD","SG9999001226.SGD","02419","SG9999015945.SGD","BK1610","LU0985320562.USD","LU1960683339.HKD","BK1531","LU0488056044.USD","BK1195","SG9999014880.SGD","LU0049853897.USD","LU1720050803.USD","LU1804176565.USD","LU0107464264.USD","IE00B031HY20.USD","LU1568876335.HKD","LU0890818403.SGD","LU2125910500.SGD","SG9999000418.SGD","02391","BK1095","LU0229945570.USD","IE00B29SXG58.USD","LU1917777945.USD","LU0594300419.USD","LU0314109678.HKD","LU0348805143.USD","LU0359201612.USD","02678","LU1282651048.USD","BK1523","06100","SG9999015978.USD","LU0499858602.USD","LU0417516738.SGD","LU0359202008.SGD","HXXD.SI","LU0359201885.HKD","LU1316542783.SGD","LU1770036033.HKD","LU0289960550.SGD","03650","LU0293314216.USD","LU0417516902.SGD","LU2242644610.SGD","SG9999015986.USD","LU1629966141.USD","BK1237","09878","LU0577902298.EUR","BK1233","BK1613","LU0675040207.SGD","LU1993786604.SGD","09857","LU0708995153.HKD","LU2476274720.SGD","LU1102505929.USD","LU2362541513.USD","LU0737861699.HKD","LU0163747925.USD","LU0865486749.SGD","LU0011963245.USD","LU1226287875.USD","HK0000252160.HKD","09669","IE0031814852.USD","IE00BZ08YT58.USD","IE00B0169N27.USD","LU1733274390.USD","LU0540923850.HKD","LU0873338254.USD","LU1046422090.SGD","SG9999018865.SGD","BK1574","BK1253","LU2237443465.HKD","LU0786609619.USD","LU3063872942.SGD","LU1152091168.USD","XIACY","LU0049112450.USD","LU0572940350.SGD","TCHmain","LU0054237671.USD","LU1439102457.SGD","LU0608807946.USD","GB00BDT5M118.USD","LU0181495838.USD","LU2097828474.EUR","LU0348814723.USD","LU2125910849.SGD","01868","LU1188198961.HKD","LU1961090484.USD","LU1733274473.HKD","LU0431992006.USD","SG9999001689.USD","SG9999014906.USD","SG9999014674.SGD","LU0593848301.USD","LU1242518857.USD","SG9999000459.SGD","LU1102505762.USD","SG9999006597.SGD","LU2133065610.SGD","01458","IE0003851619.USD","LU1323998911.USD","LU1439103000.SGD","LU1048484197.HKD","LU2265009873.SGD","BK1215","LU0886674414.USD","LU1211504680.USD","LU2460026573.USD","BK1105","02621","LU0700851271.USD","LU1044876610.USD","LU0117844026.USD","LU0862451837.USD","LU0143863198.USD","LU0132412106.USD","LU0203345920.USD","LU0456846285.SGD","LU2362541273.HKD","LU1688375341.USD","IE00BQXX3C00.GBP","LU0572944931.SGD","LU0043850808.USD","BK1586","LU1023057109.AUD","IE0008368411.USD","LU0096374516.USD","LU0828237940.HKD","02869","BK1100","LU1044875133.USD","LU0882747503.HKD","LU0048580855.USD","IE0001KFT4U8.USD","BK1526","BK1502","LU0029875118.USD","LU2097828631.EUR","LU2237443382.USD","LU1568876251.USD","LU0831103253.SGD","LU0862451753.SGD","LU1769817096.USD","00909","IE00BQXX3D17.EUR","LU2251237306.USD","LU0348784397.USD","LU0348723411.USD","BK1155","SGXZ81514606.USD","08017","LU0856984785.SGD","LU1224444064.USD","LU0061477393.USD","BK1109","LU0577902611.USD","LU0348767384.USD","09959","IE0008369823.USD","LU0048388663.USD","01274","LU0173614495.USD","BK1589","LU0577902371.SGD","BK1131","LU0210533765.USD","LU0048597586.USD","LU0823038988.USD","LU0572939691.SGD","02018","02142","LU2251237488.HKD","LU1196710195.USD","HK0000500386.USD","LU0979878070.USD","LU1981816686.USD","HK0000165453.HKD","LU0348783662.USD","IE0008368742.USD","LU1366334578.USD","LU2106854487.HKD","LU1868838027.USD","BK1221","06831","IE00B0169L03.USD","LU1956131251.USD","LU0543330566.HKD","LU1282648689.USD","LU0738912210.USD","LU0203347892.USD","LU1880383440.USD","LU1242518931.SGD","LU1794554557.SGD","HK0000320264.USD","LU0823426308.USD","LU1282651121.HKD","LU0345776255.USD","LU2778985437.USD","BK1508","LU0348827113.USD","LU0594300179.USD","BK1247","IE0003895053.USD","81810","LU0175139822.USD","IE00B031HW06.USD","LU2399975544.HKD","LU1883866441.USD","02866","IE00BPRC5H50.USD","LU0577902538.SGD","LU2023250504.SGD","BK1583","LU1282649810.SGD","LU0541502299.USD","SG9999015952.SGD","BK1575","LU1008478684.HKD","LU0165289439.USD","LU1152091754.HKD","01672","BK1542","IE00B97KM107.HKD"],"gpt_icon":1},{"id":"1195666015","title":"62-Year-Old Wealthy Woman Transfers Core Assets to Son, Mother-Son Fortune Totals 40 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1195666015","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195666015?lang=en_us&edition=fundamental","pubTime":"2025-12-30 08:24","pubTimestamp":1767054274,"startTime":"0","endTime":"0","summary":"A 62-year-old wealthy woman has transferred all her core assets to her son, with the combined wealth of the mother and son reaching 40 billion yuan. On the evening of December 29, HEC (600673)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1173029853","title":"Sunshine Pharma (06887): Equity Transfer Among Controlling Shareholder Group Members","url":"https://stock-news.laohu8.com/highlight/detail?id=1173029853","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173029853?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:58","pubTimestamp":1767016695,"startTime":"0","endTime":"0","summary":"The Board of Directors of the Company has been informed by Mr. Zhang Yushuai and Ms. Guo Meilan, each a member of the Company's controlling shareholder group, that, in light of Ms. Guo's decision to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"gpt_icon":0},{"id":"1122363411","title":"Huafu Securities Initiates Coverage on SUNSHINE PHARMA (06887) with \"Buy\" Rating, Citing Strong Innovation Pipeline and Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1122363411","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122363411?lang=en_us&edition=fundamental","pubTime":"2025-12-23 15:24","pubTimestamp":1766474688,"startTime":"0","endTime":"0","summary":"Huafu Securities released a research report initiating coverage on SUNSHINE PHARMA (06887), highlighting its leadership in the influenza sector, solid fundamentals, and robust innovation pipeline...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","BK1191","06887"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}